What is KTTA's dilution risk score?

KTTA currently has a DilutionScore of 37/100, indicating medium dilution risk. DilutionWatch monitors KTTA SEC filings in real-time, scanning EDGAR every 60 seconds for shelf registrations, ATM offerings, warrant exercises, PIPE deals, and reverse split signals.

What SEC filings does DilutionWatch track for KTTA?

DilutionWatch tracks 25 SEC filing types for KTTA including S-3 shelf registrations, 424B prospectuses (ATM offerings), S-1 registration statements, 8-K material events, warrant exercise notices, convertible note agreements, and Form 4 insider transactions. Alerts are delivered via email within minutes of a filing appearing on EDGAR.

How does stock dilution affect KTTA shareholders?

Stock dilution occurs when a company issues new shares, reducing the ownership percentage of existing shareholders. For KTTA, common dilution events include at-the-market (ATM) stock offerings, shelf registration drawdowns, warrant exercises, and convertible note conversions. Each event increases the share count and can pressure the stock price lower.

Is DilutionWatch free for KTTA tracking?

DilutionWatch provides a free tier that shows DilutionScores and basic filing history for KTTA. Premium plans ($19.95/month Basic, $39.95/month Premium) unlock real-time email alerts, the full Pulse™ feed, advanced dilution forecasts, and access to all 10,000+ tracked tickers.

KTTA Dilution Risk Score: 37/100 (MEDIUM)

📊 Score Breakdown

📋 Offering Ability

60

💰 Cash Runway

0

📊 Float Risk

37

⚠️ Warrant Exposure

15

🔄Convertible Debt—

🌦️ Dilution Forecast

🌥️

Advisory

Moderate dilution signals present

27%

🔄 Reverse Split 55%

• 50-day avg $0.75 below $1 exchange minimum

🔔 Track KTTA — Get forecast alerts →

💹 Market Data

Market Cap$23.90M

Shares Outstanding33.41M

Float18.68M

Cash$50.40M

DebtN/A

Short InterestN/A

🏛 Institutional Holdings

QoQ: ↑ 32.4% shares (2026Q1 vs prior)

21 institutional holders · 17.07M shares

#1 Vivo Capital, LLC 4.20M shares

#2 JANUS HENDERSON GROUP PLC 4.20M shares

#3 Squadron Capital Management LLC 2.10M shares

+ 17 more holders Sign up free to view →

📉 Short Interest

Short Interest287.3K

Days to Cover1.0

% of Float1.5%

FINRA data as of Jun 30, 2026

👤 Insider Buy/Sell Ratio

📁 Recent SEC Activity

xbrl XBRL WARRANT Dec 31, 2025

8-K 8K EVENT May 04, 2026

3 FORM3 Apr 17, 2026

Full SEC filing analysis available with free account →

📰 Recent News

Pasithea Therapeutics Says Interim Phase 1 Data for PAS-004 Show Durable Clinica MT Newswires · Jun 30

Pasithea Therapeutics Announces Positive Interim Phase 1 Advanced Cancer Study D GlobeNewswire · Jun 30

Pasithea Therapeutics Amends PAS-004 Trial to Add Higher Dose Levels, Extend Tre MT Newswires · Jun 16

📋 What This Means for KTTA Shareholders

Pasithea Therapeutics Corp. (KTTA) has a DilutionScore of 37/100, rated Medium dilution risk. This tier indicates some dilution exposure — often an older shelf registration with remaining capacity, warrants not yet exercised, or a cash position that will require monitoring over the next several quarters. Score as of July 14, 2026.

DilutionWatch tracks 1.2M outstanding warrants for KTTA. Warrants become dilutive when exercised — converting to common shares at the strike price. Warrants near or in-the-money deserve particular attention since exercise can add materially to the outstanding share count within a short window.

DilutionWatch tracks over 25 SEC filing types for KTTA in real-time, scanning EDGAR every 60 seconds. Recent 8-K filings are present; material events disclosures can sometimes precede or accompany capital raises. The DilutionWatch screener shows real-time score changes for KTTA alongside comparable medium-risk stocks. Not financial advice — this analysis is for informational purposes only.

Warrants Explained →